Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

08.10.20	Lilly, Gates Foundation To Supply Potential COVID-19 Therapy For Low, Middle Income Countries (RTTNews)
08.10.20	CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch (RTTNews)
07.10.20	Eli Lilly Submits Initial Request For Emergency Use Authorization To Treat COVID-19 (RTTNews)
06.10.20	Eli Lilly: REYVOW Shows Superiority Over Placebo In Migraine Pain Relief At 2 Hours (RTTNews)
18.09.20	Lilly, Incyte: CHMP Adopts Positive Opinion For Baricitinib In Treatment Of Atopic Dermatitis (RTTNews)
17.09.20	Eli Lilly, Amgen Ink Antibody Manufacturing Deal To Boost Supply For COVID-19 Therapies (RTTNews)
16.09.20	Lilly: BLAZE-1 Interim Data Show LY-CoV555 Antibody Reduces COVID-related Hospitalizations (RTTNews)
15.09.20	Eli Lilly, Boehringer Ingelheim: FDA Grants Fast Track Designation To Jardiance (RTTNews)
14.09.20	Lilly, Incyte Announce Initial Data From Adaptive COVID-19 Treatment Trial - Quick Facts (RTTNews)
11.09.20	Eli Lilly: REYVOW Meets All 18 Gated Endpoints In New Phase 3 Study (RTTNews)
10.09.20	Eli Lilly To Present Clinically Meaningful Results From MonarchE Phase 3 Study At ESMO (RTTNews)
09.09.20	Eli Lilly Promotes Ilya Yuffa To SVP & President Of Lilly Bio-Medicines (RTTNews)
18.08.20	Lilly Obtains License For TYVYT From Innovent For Geographies Outside Of China (RTTNews)
05.08.20	Lilly : Empagliflozin Reduces Risk Of Cardiovascular Death Or Hospitalization For Heart Failure (RTTNews)
03.08.20	Lilly Initiates Phase 3 COVID-19 Trial Of LY-CoV555 At Long-Term Care Facilities (RTTNews)
30.07.20	Eli Lilly Announces Positive Top-line Results From EMPEROR-Reduced Phase III Trial (RTTNews)
30.07.20	Eli Lilly Boost FY20 Adj. EPS Outlook - Quick Facts (RTTNews)
30.07.20	Eli Lilly And Co. Q2 adjusted earnings Beat Estimates (RTTNews)
17.07.20	Eli Lilly Says Mirikizumab Superior To Cosentyx In Phase 3 Study - Quick Facts (RTTNews)
18.06.20	Lilly Begins Phase 3 Study To Evaluate Baricitinib In Hospitalized Adults With COVID-19 (RTTNews)
17.06.20	AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact (RTTNews)
16.06.20	Eli Lilly Reports Positive Results From Interim Analysis Of Phase 3 MonarchE Study (RTTNews)
16.06.20	FDA Approves Lilly's New Rapid-acting Insulin Lyumjev (RTTNews)
15.06.20	Lilly Starts Phase 3 Clinical Trial With Baricitinib For Hospitalized COVID-19 Patients (RTTNews)
06.06.20	The Week That Was In COVID: Russia Approves 1st COVID-19 Drug, INO Sues Vaccine Supplier... (RTTNews)
03.06.20	Eli Lilly: Taltz Shows Consistent Efficacy In Psoriatic Arthritis - Quick Facts (RTTNews)
01.06.20	Innovent Announces Results Of TYVYT In Treatment Of Locally Advanced Or Metastatic ESCC (RTTNews)
30.05.20	FDA Approves Lilly's Cyramza To Treat Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (RTTNews)
29.05.20	FDA Oks Lilly's Drug To Image Tau Pathology In Patients Being Evaluated For Alzheimer's Disease (RTTNews)
19.05.20	Eli Lilly Reports Results Of GERAS-US Study - Quick Facts (RTTNews)
07.05.20	Innovent:phase 3 Study On Advanced Lung Cancer Meets Predefined Primary Endpoint (RTTNews)
04.05.20	Junshi, Eli Lilly Agree To Co-develop JS016 Antibodies Against COVID-19 (RTTNews)
23.04.20	Eli Lilly Q1 Results Top Estimates; Lifts 2020 Profit View (RTTNews)
23.04.20	Eli Lilly And Co. Q1 adjusted earnings Beat Estimates (RTTNews)
15.04.20	Stock Alert: Eli Lilly Continues Its Uptrend (RTTNews)
07.04.20	Lilly Says New $35 Co-Pay Available Through Lilly Insulin Value Program (RTTNews)
31.03.20	Eli Lilly, Sitryx Announce Global Licensing & Research Collaboration (RTTNews)
30.03.20	Eli Lilly: Taltz Receives FDA Approval For Treatment Of Pediatric Patients (RTTNews)
24.03.20	Eli Lilly Issues Updates On Insulin Supply - Quick Facts (RTTNews)
23.03.20	Eli Lilly To Delay Most New Study Starts - Quick Facts (RTTNews)
23.03.20	Lilly Offers Free Coronavirus Tests To Indianapolis Health Care Workers (RTTNews)
12.03.20	Boehringer Ingelheim & Eli Lilly: Jardiance Granted FDA Fast Track Designation (RTTNews)
03.03.20	Eli Lilly Anticipates No Shortages Of Products Due To Coronavirus Impact (RTTNews)
02.03.20	Pfizer & Eli Lilly: FDA To Review BLA For Tanezumab - Quick Facts (RTTNews)
27.02.20	FDA Panels Backs Lilly's Cyramza As Treatment For Metastatic EGFR-Mutated NSCLC (RTTNews)
12.02.20	Lilly's Study Meets Primary Endpoint Of 75% Improvement Of Skin Inflammation (RTTNews)
10.02.20	Stock Alert: Eli Lilly Drops As Alzheimer's Drug Fails To Meet Primary Endpoint (RTTNews)
10.02.20	Eli Lilly: DIAN-TU Study With Solanezumab Fails To Meet Endpoint - Quick Facts (RTTNews)
31.01.20	Lilly Receives Positive CHMP Opinion For New Mealtime Insulin (RTTNews)
30.01.20	Eli Lilly, Incyte: Baricitinib Meets Primary Endpoint In BREEZE-AD5 Study (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Handel in Zürich: SMI verbucht Verluste
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus